The Benefit of Implantable Loop Recorders in the Diagnosis of Recurrent Syncope

Journal for Nurse Practitioners

Volumn 5, Issue 8, 2009, Pages 607-612

  Thanavaro, Joanne L ^a   Thanavaro, Samer ^a  

^a NONE

Author keywords

cardiac arrhythmias; implantable loop recorder; permanent pacemaker; unexplained syncope

Indexed keywords

EID: 69749128425     PISSN: 15554155     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nurpra.2009.03.018     Document Type: Article

References (27)

1. Brignole M., Alboni P., Benditt D., Bergfeldt L., Blanc J., Bloch Thomsen P., et al. Guidelines on management (diagnosis and treatment) of syncope-update 2004. Europace 6 (2004) 467-537
2. Blanc J., L'Her C., Touiza A., Garo B., L'Her E., and Mansourati J. Prospective evaluation and outcome of patients admitted for syncope over a 1 year period. Eur Heart J 3 (2002) 815-820
3. Disertori M., Brignole M., Menozzi C., Raviele A., Rizzon P., Santini M., et al. Management of patients with syncope referred urgently to general hospitals. Europace 5 (2003) 283-291
4. Ammirati F., Colivicchi F.M., and Santini M. Diagnosing syncope in clinical practice. Implementation of a simplified diagnostic algorithm in a multicentre prospective trial-the OESIL 2 Study (Osservatorio Epidemiologico della Sincope nel Lazio). Eur Heart J 21 (2000) 935-940
5. Brignole M., and Shen W. Syncope management from emergency department to hospital. J Am Coll Cardiol 51 (2008) 284-287
6. Sarasin F., Louis-Simonet M., Carballo D., et al. Prospective evaluation of patients with syncope: a population-based study. Am J Med 111 (2001) 177-184
7. Strickberger S., Benson D., Biaggioni I., Callans D., Cohen M., et al. AHA/ACCF Scientific Statement on the Evaluation of Syncope. J Am Coll Cardiol 47 (2006) 474-484
8. Kapoor W. Current evaluation and management of syncope. Circulation 106 (2002) 1606-1609
9. Brignole M., Sutton R., Menozzi C., Garcia-Civera R., Moya A., Wieling W., et al. Early application of an implantable loop recorder allows effective specific therapy in patients with recurrent suspected neurally mediated syncope. Eur Heart J 27 (2006) 1085-1092
10. Krahn A., Klein G., Yee R., Hoch J., and Skanes A. Cost implications of testing strategy in patients with syncope. Randomized assessment of syncope trial. J Am Coll Cardiol 42 (2003) 495-501
11. Moya A., Brignole M., Menozzi C., Garcia-Civera R., Tognarini S., Mont L., et al. Mechanism of syncope in patients with isolated syncope and in patients with tilt-positive syncope. Circulation 104 (2001) 1261-1267
12. Costantino G., Perego F., Dipaola F., Borella M., Galli A., Cantoni G., et al. On behalf of the STePS Investigators Short- and long-term prognosis of syncope, risk factors, and role of hospital admission results from the STePS (Short-Term Prognosis of Syncope) study. J Am Coll Cardiol 51 (2008) 276-283
13. Quinn J., McDermott D., Stiell I., Kohn M., and Wells G. Prospective validation of the San Francisco Syncope Rule to predict patients with serious outcomes. Ann Emerg Med 47 (2006) 448-454
14. Sun B., Mangione C., Merchant G., Weiss T., Shlamovitz G., Zargaraff G., et al. External validation of the San Francisco Syncope Rule. Ann Emerg Med 49 (2007) 420-427
15. Alboni P., Brignole M., Menozzi C., Raviele A., Del Rosso A., Dinelli M., et al. Diagnostic value of history in patients with syncope with or without heart disease. J Am Coll Cardiol 37 (2001) 1921-1928
16. Chen L., Chen M., Larson M., Evans J., Benjamin E., and Levy D. Risk factors for syncope in a community-based sample (the Framingham Heart Study). Am J Cardiol 85 (2000) 1189-1193
17. Soteriades E., Evans J., Larson M., Chen M., Chen L., Benjamin E., et al. Incidence and prognosis of syncope. N Engl J Med 347 (2002) 878-885
18. Ahmad S., and Beckett M. Value of serum prolactin in the management of syncope. Emerg Med J 21 (2004) e
19. Brignole M., Menozzi C., Bartoletti A., Giada F., Lagi A., Ungar A., et al. A new management of syncope: prospective systematic guideline-based evaluation of patients referred urgently to general hospitals. Eur Heart J 27 (2006) 76-82
20. Kühne M., Schaer B., Moulay N., Sticherling C., and Osswald S. Holter monitoring for syncope: diagnostic yield in different patient groups and impact on device implantation. QJM 100 (2007) 771-777
21. Assar M., Krahn A., Klein G., Yee R., and Skanes A. Optimal duration of monitoring in patients with unexplained syncope. Am J Cardiol 92 (2003) 1231-1233
22. St. Jude Medical. Available at: http://www.+.com/devices/device.aspx?name=SJM+Confirm+Implantable+Cardia c+Monitor&type=53&location=us Accessed February 15, 2009.
23. Metronic, Inc. Available at: http://www.medtronic.com/your-health/fainting/device/our-insertable-card iac-monitors/reveal-icm/index.htm Accessed February 15, 2009.
24. Lombardi F., Calosso E., Mascioli G., Marangoni E., Donato A., Rossi S., et al. Utility of implantable loop recorder (Reveal Plus®) in the diagnosis of unexplained syncope. Europace 7 (2005) 19-24
25. Boersma L., Mont L., Sionis A., García E., and Brugada J. Value of the implantable loop recorder for the management of patients with unexplained syncope. Europace 6 (2004) 70-76
26. Nierop P., Van Mechelen R., Van Elsäcker A., Luijten R., and Elhendy A. Heart rhythm during syncope and presyncope: results of implantable loop recorders. Pacing Clin Electrophysiol 23 (2000) 1532-1538
27. Inamdar V., Mehta S., Juang G., and Cohen T. The utility of implantable loop recorders for diagnosing unexplained syncope in 100 consecutive patients- five-year, single-center experience. J Invasive Cardiol 18 (2006) 313-315